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 Mycobacterium tuberculosis is still the most significant single species of bacteria causing 19 
disease in mankind.  The ability of M. tuberculosis to survive and replicate within host 20 
macrophages is a pivotal step in its pathogenesis.  Understanding the microenvironments that M. 21 
tuberculosis encounters within the macrophage and the adaptations that the bacterium undergoes 22 
to facilitate its survival will lead to insights into possible therapeutic targets for improved 23 
treatment of tuberculosis.  This is urgently needed with the emergence of multi- and extensively- 24 
drug resistant strains of M. tuberculosis. Significant advances have been made in understanding 25 
the macrophage response on encountering M. tuberculosis.  Complementary information is also 26 
accumulating regarding the counter responses of M. tuberculosis during the various stages of its 27 
interactions with the host.  As such, a picture is emerging delineating the gene expression of 28 
intracellular M. tuberculosis at different stages of the interaction with macrophages.   29 
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INTRODUCTION 35 
 Mycobacterium tuberculosis (M.tb) is the etiological agent of tuberculosis (TB) and is the 36 
leading cause of infectious death in adults due to a single bacterial species 1.  It is estimated that 37 
every year there are approximately 8 million new cases of TB, and that TB is the cause of around 38 
2-3 million deaths worldwide 301.  Synergy with the human immunodeficiency virus (HIV), along 39 
with the emergence of multidrug resistant TB (MDR) and the newly identified extensively drug 40 
resistant (XDR) strains 2 threatens to make the disease incurable once again.   41 
 42 
 M.tb is a facultative intracellular pathogen possessing mechanisms for evading and subverting 43 
host immune responses.  Only 10% of people infected with M.tb develop clinical disease over 44 
their lifetime.  Thus, there is obviously a struggle between pathogen and host, with the outcome 45 
of any infection being greatly affected by variation in host susceptibility 3 4 5 6and mycobacterial 46 
virulence 7 8.  That pathogenic mycobacteria are able to survive within macrophages (M) and 47 
granulomas (both components of the host defence system) demonstrates that they have 48 
mechanisms enabling them to inhibit, endure or evade cell-mediated immunity.   It is logical to 49 
propose that specific mycobacterial genes are critical for the survival and virulence of M.tb 50 
within the host.  This hyopothesis has led to numerous studies, using a wide range of 51 




 The production of transposon mutant libraries in mycobacteria 9 10 has enabled the study of a 2 
number of potential virulence factors.  Signature tagged mutagenesis has been used to identify 3 
mutants that do not survive in vivo 11 12, whereas saturation mutagenesis of M.tb has identified 4 
mutants that can not survive in vivo 13 or in M 14. While informative, these studies have 5 
identified only the genes that are essential for the survival of M.tb in M and animal models.  6 
Obviously this is important information that can be used in the search for new therapeutics but it 7 
does not highlight conditionally essential genes required in additional phases of infection, or 8 
allow for the identification of non-essential genes that mediate the differences seen when 9 
comparing, for instance, virulent and avirulent strains.   10 
 11 
 Gene expression profiling on a global level has been investigated widely using such methods 12 
as microarray analysis, subtractive hybridisation and differential display.  Differential display of 13 
RNA from two populations of bacteria (e.g. broth grown versus inside a M) is a sensitive 14 
method that requires very small amounts of RNA.  However, relatively large numbers of 15 
candidate bands must be checked to find a few differential bands and rare mRNA transcripts are 16 
very hard to detect without nested priming 15.  Subtractive hybridization has been used to 17 
eliminate bacterial genes commonly expressed in both M and broth culture 16 17 18. The 18 
remaining genes are then assumed to be specifically expressed in one or the other environment.  19 
Another approach to identifying genes expressed in M is to construct a library of mycobacterial 20 
genomic DNA in a promoter capture vector, with the DNA inserted upstream of a promoterless 21 
Green Fluorescent Protein (GFP) gene.  Thus, only plasmids containing an active promoter will 22 
express GFP.  This library is transformed into the mycobacteria of interest which are then used to 23 
infect Ms.  Any promoter constructs that are more actively expressed in the Ms can be 24 
identified using fluorescent readout methodologies 19 20 21.  Subtractive hybidization and 25 
promoter capture have been used successfully to identify genes expressed by mycobacteria within 26 
Ms.  However, both methods have drawbacks in that they are technically demanding and are 27 
prone to identifying genes that can be found in both pathogenic and non-pathogenic 28 
mycobacteria.  29 
 30 
 Post-genomic studies offer the potential for identifying putative virulence genes by utilising 31 
microarray technology to define the changing pattern of M.tb gene expression during infection 22.  32 
DNA sequences representing the open reading frames (ORF) for all genes from (a) reference 33 
genome(s) are printed or synthesised on a glass slide (or chip) which is then probed with cDNA 34 
derived from M.tb RNA.  The fluorophore-labelled cDNA is co-hybridised in a competitive 35 
reaction against cDNA (labelled with an alternative fluorophore) derived from a different 36 
condition in a direct comparison, or against a DNA reference that allows multi-way comparisons 37 
between RNA samples. The normalized ratio of the fluorophores for each gene reflects the 38 
change in RNA abundance between the two conditions. Developments such as the use of 39 
genome-directed primers 23, bacterial RNA amplification 24, and high-density microarray 40 
platforms have expanded the range of infection models tractable to investigation and the global 41 
nature of the data acquired. The application of transcriptome sequencing using next-generation 42 
methodologies will clearly improve the genomic resolution of these studies further.     43 
 44 
 Another approach for studying transcriptomes is the use of Bacterial Artificial Chromosome 45 
(BAC) arrays.  They have previously been used to compare mycobacterial genomes 25 26 27 28 and, 46 
more recently to compare the transcriptomes of intracellular M.tb strains 29 30.  Genomic DNA is 47 
cloned into BACs and the clones are positioned on a restriction enzyme map of the genome to 48 
produce a set of BACs that cover the genome. Southern blots of BAC digests can be hybridized 49 
with cDNA from two transcriptomes and non hybridizing fragments in one or the other sample 50 
can be identified.  A drawback to this method is that each band produced by the restriction digest 51 
of each BAC does not necessarily represent a single gene.  The absence of a gene within a band 52 
may, therefore be masked by a positive hybridisation with other genes within that same band.  53 
 3 
 
Conversely, the presence of multiple genes in a band can be advantageous in identifying 1 
differences in the expression of operons 30. 2 
 3 
OVERVIEW OF THE INFECTIOUS PROCESS 4 
 M.tb bacilli first encounter host Ms following their inhalation into the alveolar spaces of the 5 
lung.  It is here where they will encounter the alveolar M.  The first stage of the interaction is 6 
the attachment of the bacteria to the M, followed by ingestion via phagocytosis (see Fig 1).   7 
During this process, the bacterium may be exposed to potentially toxic agents such as reactive 8 
oxygen intermediates (ROI).  They will also trigger the production of cytokines and chemokines 9 
by the M which play pivotal roles in the induction of innate immunity, adaptive immunity and 10 
apoptosis.  Following ingestion the bacterium resides within an intracellular compartment called 11 
a phagosome where they are potentially exposed to additional killing mechanisms such as 12 
lysosomal hydrolases, antimicrobial peptides and glutathione.  In addition, they must acquire 13 
nutrients while residing in this intracellular compartment of the M usually associated with 14 
digestion and recycling of senescent cellular debris.  Another important adaptation the TB 15 
bacillus must make is the move to a lower oxygen tension within the M.   Obviously some 16 
bacteria survive this initial move to the intracellular environment where they can then replicate.  17 
One outcome of this replication is the release of bacteria from the initial contact cell to other local 18 
host cells such as dendritic cells and newly arriving elicited Ms.  Another outcome of bacterial 19 
replication is that the host develops adaptive immunity leading to the interferon- (IFN)-20 
mediated activation of infected Ms.  Activated Ms are better able to control bacterial 21 
replication through enhanced killing mechanisms such as the production of ROI and reactive 22 
nitrogen intermediates (RNI), phagosomal maturation to lysosomes, and apoptosis.  The exposure 23 
to adaptive immune responses triggers a shift of the bacterial physiology towards a so called 24 
dormant or chronic phase.  In this state, M.tb utilises lipids as a carbon source and the glyoxalate 25 
shunt for energy production.  The host response to the persisting bacteria is to form a highly 26 
organised granuloma that walls off the bacteria in an hypoxic environment where they are 27 
commonly found within foamy macrophages.  This granuloma may calcify over time or may 28 
cavitate and break through to the airways, releasing bacteria to begin the cycle again. 29 
 30 
 There are a number of critical steps during the cycle of M.tb pathogenesis that result in 31 
changes to the environment in which the bacterium finds itself.  Many of these key phases of 32 
infection involve changes to the MΦ-bacterial interplay.  Although M.tb has been shown to enter 33 
neutrophils 31 32 and epithelial cells 33 34, the M is considered to be the host cell in which the 34 
bacteria most commonly reside.  While the role of neutrophils and epithelial cells in the 35 
pathogenesis of M.tb is still uncertain, the central role of the M is generally accepted as a major 36 
component in the host/pathogen interaction in TB.  Thus, this review will concentrate on the 37 
expression of genes by M.tb during its interaction with Ms.  Additionally, although numerous 38 
informative studies have identified expression differences between broth grown M.tb and bacteria 39 
obtained from the human lung and animal infection models, or by using model organisms like M. 40 
bovis BCG 35 36 37 38 39 40, we have restricted our review to studies utilising M.tb in the context of 41 
life inside the M. 42 
 43 
 44 
BINDING AND UPTAKE (MOVEMENT FROM EXTRACELLULAR TO INTRACELLULAR) 45 
 Because mycobacteria are predominantly found within Ms and are known to survive and 46 
replicate within that niche, it is generally believed that they have evolved strategies that facilitate 47 
their association with phagocytes.  It is often assumed that mycobacteria readily enter any MΦ 48 
they encounter and it is only then that survival mechanisms of bacterial origin come into play.  49 
However, there is evidence that MΦ populations vary in their ability to efficiently associate with 50 
M.tb 41 42.  Thus, evidence is accumulating to suggest that pathogenic mycobacteria are not 51 
automatically bound and ingested by the first MΦ they encounter on inhalation.  On the contrary, 52 
M.tb bacilli appear to have developed strategies to control their ingestion by Ms, which 53 
includes a capsule that acts to regulate the receptor-ligand interactions between M.tb and Ms 43.   54 
 4 
 
Host-derived serum opsonins can greatly enhance the uptake of mycobacteria by most MΦ 1 
populations 44 45 42, though not by resident alveolar Ms 42.  The serum-independent interaction 2 
of M.tb with Ms is considered to be important in the early stages of pulmonary infection 3 
because the lung is an environment in which serum opsonins are relatively scarce or absent 46 47 4 
and alveolar MΦs have low levels of receptors for serum opsonins 48 42.  Serum-mediated uptake 5 
of M.tb may be more important at later stages of the infection, when bacteria encounter elicited 6 
MΦs 41 42.  Thus, in the absence of significant levels of serum (a situation encountered by M.tb on 7 
entering the lung) M.tb appears to have developed strategies to limit its association with MΦs and 8 
to direct its entry into certain sub-populations of MΦs.  Entry of M.tb into the MΦ appears to rely 9 
on bacterial adherence to MΦ receptors/surface molecules followed by phagocytosis, with no 10 
substantial evidence for active mechanisms of bacterial invasion.   Numerous receptors have been 11 
implicated in mediating the serum-independent entry of M.tb into MΦs including the mannose 12 
receptor 49, the lipopolysaccharide receptor (CD14), 50, surfactant protein receptors A 51, the 13 
complement receptor CR3 52, and CD43 53 54.  14 
 15 
 It might be expected that binding and ingestion of M.tb to MΦ would trigger the induction of 16 
a number of genes to prepare the bacterium for the major changes in oxygen tension, nutrient 17 
availability and exposure to toxic molecules.  Surprisingly, the attachment of M.tb to MΦ did not 18 
alter bacterial gene expression, as measured by microarray with a >1.5x fold change in 19 
expression compared to M.tb bacilli resuspended in MΦ culture media alone 55.  However, uptake 20 
of the bacteria over 2 hours resulted in transcriptional responses commencing within minutes and 21 
resulting in distinct changes in gene subsets over time 55. These included members of the WhiB 22 
family of transcriptional regulators, members of the devR (also known as dosR) regulon involved 23 
in the response to hypoxia and ROI and  >50% of the phoPR regulon, including genes involved in 24 
cell wall remodelling.   25 
 26 
 Several groups have defined the transcriptome of intracellular M.tb from 4h to 48h after MΦ 27 
infection, describing the changes in gene expression between broth grown and intracellular M.tb. 28 
Many additional studies have investigated specific parameters considered to be representative of 29 
the intracellular environment, such as hypoxia or low pH, and have been used to deconvolute the 30 
complex patterns of gene expression observed after macrophage uptake.  Figure 2 illustrates the 31 
overlap of gene subsets between the intracellular transcriptional signatures derived from MΦ 32 
infection models and microarray experiments designed to mimic specific environmental stresses 33 
that M.tb may encounter during infection.  Interestingly, there is limited overlap between all 34 
intracellular transcriptomes (A-D).  However, common functionalities of regulated gene sets are 35 
repeatedly identified (E-S).   These include genes indicative of fatty acid metabolism, cell wall 36 
metabolism and restructuring, iron metabolism, DNA damage repair, nutrient deprivation, 37 
transcriptional regulation and a response to hypoxia including the devR regulon 56 57 58 59 55 60.  38 
These differences are taken to imply that the bacterium has moved to an environment low in 39 
carbohydrate yet relatively lipid rich, where it encounters a low oxygen tension, and is exposed to 40 
potentially toxic mechanisms requiring restructuring of the cell wall and the utilization of defence 41 
mechanisms.  The specific events following uptake of M.tb by MΦ have been modelled and 42 
investigated in some detail. 43 
 44 
RESIDENCE IN A PHAGOSOME AND THE ASSOCIATED LOW NUTRIENTS, INCREASED ACIDITY AND 45 
HYPOXIA. 46 
 The bacterial phagosome is a defining feature of M.tb pathogenesis as it differs from most 47 
particulate endosomes.  There are numerous studies in which this compartment has been 48 
modelled in a cell free system.  Following the phagocytosis of most particles, the phagosome will 49 
mature along the phagosomal-lysosomal pathway, sequentially acquiring markers from early 50 
endosomes (such as transferrin receptors, mannose receptors and Rab5), late endosomes (such as 51 
LAMPs, cathepsin D and Rab7) and lysosomes (such as LAMPs, and cathepsin D) via a “kiss 52 
 5 
 
and run” phenomenon 61 62.  The phagosome also progressively acidifies down to pH5.5, or 1 
lower, following fusion with late endosomes and lysosomes 63 64. However, pathogenic 2 
mycobacteria such as M.tb subvert this phagosome maturation, presumably to aid in their 3 
survival within the MΦ.  Seminal work by Hart first demonstrated that mycobacterial 4 
phagosomes did not fuse with lysosomes 65.  This observation was extended to show that M.tb 5 
arrests maturation of the phagosome to reside in an early endosomal-like compartment that can 6 
interact with other endosomes, thereby obtaining nutrients for its survival.  The M.tb phagosome 7 
contains the early endosome markers glycosphingolipids 66, transferrin 67 and Rab5 but excludes 8 
the late endosome marker Rab7 68.  However, the late endosomal-lysosomal markers LAMP-1 9 
and cathepsin D do appear to be found in the M.tb phagosome 69 70 (Fig 1). 10 
 11 
 The mycobacterial phagosome remains at pH 6.2-6.3 displaying a reduced acidification when 12 
compared to those containing control particles 71 72 .  This has been attributed to a paucity of 13 
proton ATPase pumps on the M.tb phagosome 69 73.  Evidence has been presented to explain how 14 
mycobacteria bring about the reduced acidification and arrest of maturation of their phagosome.  15 
Galectin 3 74, coronin1 (TACO) 75 and degraded cellubrevin 76 have all been found to accumulate 16 
on the M.tb phagosome but, as yet, no mechanism for their activity has been fully defined.  The 17 
mycobacterial cell wall associated glycolipids, lipoarabinomannan 77 78 and cord factor 79 have 18 
been shown to inhibit phagosome maturation, though again, no mechanistic explanation has been 19 
determined.  Inhibition of intracellular calcium by mycobacteria has also been shown to inhibit 20 
phagosome maturation 80 through the inhibition of sphingosine kinase 81.  In addition, transposon 21 
mutants of M.tb that fail to prevent the maturation of phagosome development have been 22 
identified and the genes involved were found to include putative transporters, lipid synthesis 23 
enzymes 82 and several mutations in the ESX-1 secretion pathway 83. The importance of the 24 
proteins secreted by the ESX-1 pathway in down-regulating MΦ responses and in the virulence 25 
of M.tb has been recently reviewed 84. That progression of endosomal maturation is deleterious to 26 
the survival of M.tb has been suggested by numerous studies 82 85 86 87, though it is difficult to 27 
differentiate whether the death of intracellular M.tb is the result of, or precedes the development 28 
of, phagosome maturation. 29 
 30 
 Exposure of M.tb to various models of the phagosome has resulted in a better understanding 31 
of the M.tb transcriptional response to this niche.  Although the M.tb phagosome is held at a 32 
modified early endosome stage, thereby allowing access to some extracellular nutrients, there is 33 
still a level of nutrient deprivation the bacterium has to contend with, including low levels of 34 
iron.  Growth of M.tb in a chemostat under nutrient depletion resulted in the bacteria entering a 35 
non-replicative state and an up-regulation of genes involved in β oxidation of fatty acids 88.  36 
Starvation of M.tb led to a downregulation of 15% of the energy metabolism genes, 47% of the 37 
aerobic respiration genes, 59% of the genes involved in ribosomal protein synthesis and 16% of 38 
the lipid biosynthesis genes 89.  Interestingly, protein analysis identified significant upregulation 39 
of the hspx gene product, -crystallin that is associated with a dormancy profile 89.  Iron 40 
starvation leads to upregulation of genes involved in iron acquisition (mbtA, mbtB, mbtI)  90 and 41 
the regulation of a variety of other proteins, including putative transporters, iron storage proteins, 42 
members of the PE/PPE family, transcriptional regulators, and enzymes involved in lipid 43 
metabolism 91. Many of these transcriptional signatures are mirrored in the intracellular gene 44 




 The regulation of genes following pH reduction is dependent on the relative acidity that M.tb 1 
is exposed to. The mild acidification (pH 6.2-6.3) seen in the “normal” M.tb phagosome results in 2 
the regulation of 162 genes, whereas exposure to a pH 5.5, that may be seen in IFN-activated 3 
Ms, results in the differential regulation of 679 genes 55.  In another study in which M.tb was 4 
exposed to a pH of 5.5, 81 genes were differentially expressed with many of the highly induced 5 
genes showing homology with nonribosomal peptide synthetases/polyketide synthases 93.  Using 6 
a promoter trap system, it was shown that acid induced the expression of lipF (a putative lipase) 7 
and Rv0834c, though neither was induced in resting MΦ phagosomes 94.  Several members of the 8 
phoP regulon were induced by acid pH as was whiB3 suggesting a role for these genes in 9 
regulation of the acid response 55.  A number of genes were only regulated by pH 5.5 and not 10 
pH6.5; these included repression of genes mediating protein synthesis, replication and energy 11 
metabolism along with induction of genes involved in stress responses, such as sigH, sigB, 12 
groEL2 and dnaJ 55. 13 
 14 
 Hypoxia is considered to be one of the most important changes for M.tb to deal with when it 15 
enters the MΦ and also when it resides within the granuloma during chronic infection.  This is 16 
reflected by the numerous studies investigating gene regulation in M.tb exposed to reduced 17 
oxygen tension 95 96 97 98 99 30.  The two-component response regulator devR-devS (dosR-dosS; 18 
Rv3133c/Rv3132c) was originally shown to be up regulated during hypoxia along with a regulon 19 
of around 50 genes including hspX (-crystallin), fdxA, narX, narK2, bfrB and ctpF 95 96. Later 20 
studies confirmed and extended these results using controlled oxygen depletion in a chemostat 97.  21 
In addition to up-regulation of the devR regulon, six of the ten contiguous mycobactin synthesis 22 
genes (mbtA- L) were up-regulated.  A comparison of aerobic cultures of M.tb with 23 
microaerophilic and anaerobic cultures 100  revealed   similarities and differences between the two 24 
gene sets from the hypoxic M.tb 98.  Lycine dehydrogenase, nitrate reductase and -crystallin 25 
were induced in both treatments, as were genes of the devR regulon and fatty acid metabolism 26 
genes including fadD26.  Induction of the fumarate reductase operon (frdA-D) following hypoxia 27 
has been shown for M.tb, presumably as an adaptation to anaerobic respiration 30.  Interestingly, 28 
while M.tb grown under hypoxic conditions was more virulent in a guinea pig model 97, a devR 29 
deletion mutant had no decreased virulence in a murine model of TB 99, suggesting that the devR 30 
regulon may be redundant with regards bacterial virulence in mice.  Additional analysis showed 31 
that induction of the devR regulon is transient and is replaced by an “enduring hypoxic response” 32 
of 230 genes induced at 4 and 7 days of hypoxia.   A meta-analysis of the transcriptional network 33 
(origons) differentially expressed in response to hypoxia over time 101, identified the devR , sigD 34 
and Rv0494 as early origons (response on or before day 6 of hypoxia).  Intermediate (day 8-14) 35 
origons included furB/zur, crp, sigH, kstR and sigE-mprA; while nadR, Rv1956 and hrcA were 36 
late origons (>20 days after hypoxia). 37 
 38 
EXPOSURE TO POTENTIAL MYCOBACTERIACIDAL AGENTS AND PROCESSES  39 
 Invading microbes, including pathogens like M.tb, can be killed by Ms in a number of 40 
ways 102.   MΦ killing mechanisms that have been shown to be deleterious to M.tb include fatty 41 
acids 103, defensins 104 ATP-mediated killing 105, autophagy 106 107, glutathione and 42 
nitrosoglutathione 108, p47 GTPases 109 lysosomal ubiquitin derived peptides 110, the lysosomal 43 
enzyme beta-hexosaminidase 111 and the induction of endosomal maturation into phagolysosomes 44 
112 113 114 82 115 86.  However, the major mechanisms that have repeatedly been described as having 45 
 7 
 
antimycobacterial activity are the production of ROI and RNI 116 117 118 119 and the induction of 1 
apoptotic cell death of infected Ms 120 121 122 123. 2 
 ROI:  MΦ produce ROI (superoxide anion, hydrogen peroxide, singlet oxygen) during the 3 
ingestion of many types of particles 124 116.  ROI are able to kill mycobacteria 125 126.  In addition, 4 
it has been shown that phox knockout mice, which are unable to produce ROI, are more 5 
susceptible to M.tb than their wild type littermates 127 128, demonstrating the involvement of ROI 6 
in killing M.tb.  Moreover, a katG knockout strain of M.tb was markedly attenuated in wild-type 7 
C57Bl/6 mice and iNOS knockout mice (that can not make RNI), yet was indistinguishable from 8 
wild-type M.tb in its ability to replicate and persist in phox knockout mice 129. As there is some 9 
redundancy in phox 116, it is most probable that ROI play a role in the killing of intracellular 10 
mycobacteria but that this is not an exclusive role. 11 
 RNI:  RNI (nitric oxide, the nitrite ion, nitrous anhydride and peroxynitrite) are considered 12 
to be involved in the killing of mycobacteria and other microbes by MΦs, either independently or 13 
in conjunction with ROI 116 117 130 131.  RNI are produced by MΦs in response to multiple signals 14 
and, like ROI, are generally considered to be the result of MΦ activation by a priming (e.g IFNγ) 15 
and an activating signal (e.g.LPS ) 117.  Studies using iNOS knockout mice 132 127 133 16 
demonstrated that RNI are an important component of the antimycobacterial armature of the 17 
murine MΦ though, like ROI, there is some redundancy in iNOS 116 134.  Mice with a combined 18 
deficiency in Phox and iNOS die of spontaneous microbial infections, illustrating the need for at 19 
least one system to be present to fight infection 135. Recent studies have shown that RNI do not 20 
gain access to the mycobacterial phagosome 136 and there is evidence that RNI do not mediate the 21 
killing of M.tb in MΦs via a direct action on the intracellular bacteria 137.  Thus, the mechanism 22 
of RNI toxicity to intracellular M.tb is more complex than was first thought.  There is some 23 
controversy as to whether MΦ production of RNI is a killing mechanism that can be employed by 24 
human MΦs 138 139 140, however, evidence is accumulating that demonstrates that human 25 
phagocytes can produce RNI, albeit under tighter regulation than in the murine system 141 142 143 26 
144 145 119.  Thus, whether RNI actually play a role in killing M.tb in human MΦs is still 27 
unresolved.  28 
 Apoptosis:  Apoptosis is the process of programmed cell death involving a cascade of 29 
intracellular signals that results in the death of damaged, infected, or redundant cells without 30 
inducing an inflammatory response and the associated damage of surrounding cells.  Ligation of 31 
apoptotic triggers, such as TNFα, with its receptor, TNFR, leads to the activation of caspases that 32 
are responsible for the regulated disassembly of the cell into apoptotic bodies 146.  More recently 33 
it has been shown that there are both caspase dependent 147 and independent 148 mechanisms of 34 
apoptosis within MΦ that can successfully control intracellular microbes.  It has been shown that 35 
apoptosis is a mechanism that is employed by the host to eliminate MΦs infected with 36 
mycobacteria 149 150 151 152 123.  Moreover mycobacteria (and other pathogens) have been 37 
demonstrated to be able to inhibit the apoptotic pathways of MΦs, at least to some extent, 38 
resulting in survival of the intracellular bacteria 153 154 152 155.  Recent studies have identified 39 
mycobacterial genes (nuoG and secA2) that are involved in inhibiting apoptosis 156 157, 40 
confirming the importance of apoptosis in MΦ control of M.tb. 41 
 42 
 Changes to the transcriptome of M.tb exposed to multiple ROI and RNI donors have been 43 
investigated. Hydrogen peroxide was shown to induce the devR regulon, but at relatively low 44 
levels compared to other stress conditions, including nitrosoglutathione 158.  As would be 45 
expected, the catalase gene, katG is upregulated following H2O2 treatment 
159.   Exposure of M.tb 46 
to RNI regulated a similar set of genes as did hypoxia, including devR/devS, nrdZ, narK2, narX, 47 
 8 
 
pfkB, hspX, ctpF and a number of hypothetical proteins 160 161.  An alternative approach, 1 
comparing transcriptomes of M.tb in iNOS knockout MΦs versus wild type MΦs gave similar 2 
results and identified an NO-induced response that represented a shift from aerobic to anaerobic 3 
respiration (induction of the devR regulon) and increased iron scavenging and utilisation of fatty 4 
acids as a carbon source.  56.  Unfortunately, no information is available for gene regulation of 5 
M.tb within apoptotic MΦ, although, as both ROI and RNI induce apoptosis, the studies 6 
comparing M.tb gene expression in the presence of these toxic molecules may reflect what would 7 
be found for bacteria within apoptotic MΦ. 8 
 9 
THE INDUCTION OF ADAPTIVE IMMUNITY AND THE MOVE TO A DORMANCY PROFILE. 10 
 The early interactions of M.tb with MΦ are generally considered to take place in the 11 
absence of any adaptive immune response.  Rather, the bacteria are exposed to elements of innate 12 
immunity, of which MΦ are an important component.  Although innate immunity exerts a level 13 
of control on the replication of M.tb during the early acute phase of disease 123 162, it is only when 14 
antigen specific adaptive immunity is initiated that bacterial replication dramatically slows down 15 
and M.tb enters into a chronic stage of disease. This is characterised by minimal increase, or even 16 
slow decline, in the bacterial burden and a move towards a physiological state that is often 17 
referred to as dormancy.  That this control of bacterial replication is mediated by the immune 18 
system has been demonstrated by studies in knockout mice lacking CD4+ T cells, or with defects 19 
in the IFN activation pathway (IFN production, IFN receptor, IL-12), or with defects in TNF 20 
or RNI production.  These mice are significantly more susceptible to M.tb than intact littermates.  21 
Other components of the adaptive immune response such as CD8+ T cells are also important 163 22 
164 but do not appear to be as critical.165 166.  From these, and other studies, it is generally 23 
accepted that, while there are a number of contributory factors to adaptive immunity to M.tb, the 24 
most important elements are the production of CD4+ve TH1 cells that produce IFNγ, CD8+ve 25 
cytolytic T lymphocytes (also IFNγ producers) and TNF 167 168 169.  The most important way 26 
these critical elements mediate control of bacterial survival and replication is likely through the 27 
action of IFN and TNF on the MΦ and the granuloma.  Both IFN and TNF can act alone or 28 
in synergy to activate infected MΦs, resulting in an increase in phagosomal maturation towards a 29 
phagolysosome 170, increased ROI and RNI production by the MΦ  116 and increased apoptosis 171 30 
121, ultimately resulting in a MΦ intracellular environment that is non-permissive for 31 
mycobacterial replication.  To counter this response by the host, M.tb can down-regulate the 32 
induction of cytokines involved in the activation of MΦ.  Studies using purified mycobacterial 33 
components or directed cell wall mutants of M.tb indicate that survival of intracellular M.tb is 34 
linked to the ability to down-regulate pro-inflammatory cytokines such as IL-12, IL-6 and TNF 35 
172-174 and inhibit the activation of MΦ by IFN 175.  However, even though M.tb can modulate 36 
the cytokine response of the host, it is evident from animal infection models that this is not 37 
sufficient to prevent the activation of MΦ to a state capable of controlling M.tb growth and 38 
survival in vivo. 39 
 In response to IFN-mediated activation of the MΦ, M.tb alters its physiology to enter into a 40 
dormancy phase characterised by a drastically reduced level of replication 176or a balance 41 
between slow replication and killing 162, use of lipids as a carbon source through the glyoxalate 42 
shunt 177 and a shift towards microaerophilic respiration 178.  The IFN -mediated maturation of 43 
the phagosome will also lead to further nutrient deprivation and hypoxia.  These signals are 44 
thought to lead to a dormancy regulon that enables M.tb to persist inside the MΦ and the 45 
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granuloma.  Meta-analysis of microarray studies modelling dormancy 179, indicated several trends 1 
including up-regulation of 81% of the  devR regulon, down-regulation of over 50% of the 30S 2 
and 50S ribosomal-protein genes and down regulation of ATP synthesis.   This is indicative of a 3 
bacterium slowing down protein synthesis and shifting towards alternative electron acceptors 4 
such as nitrate or fumarate during respiration. M.tb is nominally an aerobe but is able to switch to 5 
a microaerophillic/anaerobic mode of respiration as indicated by the up-regulation of fdxA, narX, 6 
narK2 and the frd operon.   Other features of the dormancy regulon include the further induction 7 
of genes involved in the utilization of fatty acids as a carbon source and genes involved in 8 
mycolic acid modifications, indicating modification of the cell envelope 56.  As RNI are only 9 
produced by activated MΦ, it has been suggested that they may be an important trigger of 10 
dormancy in M.tb following the onset of adaptive immunity.  RNI can inhibit respiration in 11 
bacteria and it is therefore not surprising that the RNI induced dormancy regulon closely 12 
resembled that induced by hypoxia and nutrient starvation as represented by the devR regulon 160 13 
161 180.  14 
 15 
CONCLUSIONS AND CAVEATS 16 
 The move of M.tb from extracellular to intracellular residence within the MΦ is a major 17 
change in environment, requiring major adjustments to enable the bacterium to survive and 18 
flourish.  We have reviewed those environmental changes and the accompanying bacterial 19 
adaptations necessary for M.tb to succeed as a pathogen at the level of gene expression.  While 20 
there is no complete agreement among the numerous studies as to the identity of genes regulated 21 
by this adaptation, nor for that matter as to the identity of the elements of the MΦ environment 22 
that induce this regulation or indeed the multiple microenvironments that may be encountered by 23 
infecting bacilli, there is a level of consensus.   It is generally agreed that the move to an 24 
intramacrophage location will result in M.tb having to deal with changes in oxygen tension, 25 
nutrient depletion, increased acidity and exposure to immune defences such as ROI, RNI, 26 
apoptosis and phagosomal maturation.  During the early, acute stage of infection, M.tb bacilli are 27 
likely exposed to the innate immune response which includes such elements as complement, NK 28 
cells, defensins, neutrophils and resident MΦs.  Although these clearly have an effect, some 29 
bacteria seem able to adapt to or avoid these challenges and replicate relatively successfully.  30 
Following the development of adaptive immunity, the infection shifts into a chronic stage where 31 
the host’s defences are more effective at controlling bacterial replication and survival.  The 32 
bacteria are walled off in a granuloma and go into a dormant or latent phase that is maintained 33 
predominately by host IFN and TNF.   34 
 35 
 M.tb responds to these changes by rapidly changing its transcriptome.  Intracellular residence, 36 
hypoxia, nitrites and starvation all seem to induce genes characterized by the dormancy regulon 37 
that enable bacilli to undergo anaerobic respiration, utilize lipids as a carbon source and modify 38 
the cell envelope.  Many studies have shown that the devR (dosR) regulon is heavily represented 39 
in all treatments that lead to a dormancy profile in M.tb, suggesting that these genes are very 40 
important in the continued survival of intracellular bacteria.  However, recent data suggests that 41 
the devR regulon is not necessary for bacterial virulence and appears to be transiently expressed 42 
during early hypoxia (< 24 hours)  and that an enduring hypoxic response of 230 genes contains 43 
key factors needed for M.tb persistence 99.  The hspX gene encoding the 16kD -crystallin 44 
chaperonin is also commonly up-regulated in M.tb on entering MΦs and moving into dormancy.  45 
Indeed, its expression is often used as an indication of a dormant state.  However, it has been 46 
shown that letting cultures stand for 30 minutes can result in 100 fold increases in hspX 47 
expression 158, which suggests that dormancy is not the only trigger leading to increased 48 
production of this chaperonin, It appears that hspX, along with many other genes differentially 49 
expressed intracellularly, are inextricably linked to a slowing of M.tb replication after multiple 50 
stresses.  Many of the studies investigating gene expression by M.tb in MΦs have modelled the 51 
intracellular environment in axenic culture in order to determine the effect of a single variable 52 
over time, and to avoid the complications of isolating RNA from intracellular bacteria.  This has 53 
often led to exposing the bacteria to a single trigger hypothesised to reflect the phagosomal 54 
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environment, such as acidity, hypoxia, H2O2 or nitrite.   While this reductionist approach has 1 
produced valuable information, it has to be remembered that the intracellular M.tb bacilli are not 2 
exposed to each of these conditions in isolation and it is perhaps better to try and determine the 3 
bacteria’s response to intracellular life by actually looking at bacteria within the MΦ.  Perhaps 4 
more informative are studies aimed at identifying the functional significance of isolated elements 5 
of the host response by using MΦ with single gene deletants (for example, ROI or RNI) to yield 6 
single pathway inferences. Studies designed to investigate the multi-factorial nature of M.tb 7 
infection should provide new perspectives, but will have to negotiate increasingly complex 8 
networks of interaction.  9 
 10 
 The distinction between intracellular microenvironments permissive and non-permissive for 11 
M.tb growth has also been modelled by comparing the intracellular transcriptomes of different 12 
mycobacterial species and in different phagocytic cells, for example M.tb compared to BCG 55, 13 
and M.tb infection of  MΦ compared to dendritic cells 60. This raises an important element in 14 
studying the transcriptome of M.tb within the intracellular environment.   The actual model 15 
utilised i.e. the mycobacterial species and phagocyte used will have significant impact on the 16 
results obtained.  Many studies have been performed using M. bovis BCG as a model for M.tb 17 
because of the high degree of homology between  the two bacterial genomes, coupled with the 18 
relative ease with which BCG can be used experimentally (it does not require containment level 3 19 
laboratories).  However, BCG lacks an important virulence region called RD1 181, is attenuated in 20 
humans and does not result in the same pathogenesis as M.tb.    While the genome sequence of 21 
M.tb and M. bovis are very similar, the transcriptomes of the 2 species show several differences 22 
182 demonstrating the need to use M.tb in expression analysis of M.tb in MΦ.  The other major 23 
source of variation in trying to understand the intracellular phenotype of M.tb is the choice of 24 
MΦ infection model itself.  Commonly used models are the murine bone marrow-derived MΦ 25 
(BMM) 56 58 55, human monocyte-derived MΦ (MDM) 57 60 and the human MΦ-like cell line 26 
THP-1 59.  Each of these models has strengths and weaknesses.  For instance, when using MDM, 27 
significant variation between the MΦs from  individual blood donors means that greater numbers 28 
of samples are required before variation is reduced enough to characterize specific patterns.  The 29 
use of THP-1 cells overcomes this variation but introduces problems associated with it being a 30 
cell line that is not truly representative of a MΦ.  Perhaps the BMM is the best model as it 31 
represents a reasonably uniform population of MΦ that are derived from ex vivo cells and, unlike 32 
human MΦ models, results obtained in BMM in vitro can be further tested in infection models in 33 
vivo.  However, a long-standing issue with the use of murine MΦs is the strong inducible RNI 34 
response seen following immune activation.  This has been identified as one of the major 35 
determinants resulting in the induction of the M.tb intracellular dormancy program.  While it is 36 
becoming increasingly clear that human MΦs can make RNI 119, there are significant differences 37 
between human and mouse MΦ RNI production.  Additionally, strain variation between mice 38 
may also affect the results using BMM.   39 
 40 
 Finally, it is necessary to ensure that comparisons between data sets of genes take into 41 
consideration the behaviour of M.tb in the MΦ model used.  For instance, M.tb usually replicates 42 
efficiently in untreated “resting” murine BMM over 7 days in vitro and IFN treatment can slow 43 
this replication rate but does not result in bacterial elimination 183 109 123.  In one of the seminal 44 
studies on M.tb gene expression in MΦ 56, no replication was seen in resting murine BMM MΦ, 45 
and IFN stimulation resulted in bacterial elimination.  While there are many possible 46 
explanations for this disparity, it is important to ensure that variations in the models used are 47 
considered when comparing M.tb intracellular RNA profiles. An additional source of variation, 48 
particularly applicable to the use of microarray platforms to study changes in gene expression, is 49 
the choice of comparator conditions. Typically, intracellular transcriptional profiles are compared 50 
to log phase axenic bacilli, or bacilli resuspended in tissue culture media alone. Transcriptional 51 
differences between these bacterial populations will necessarily affect the interpretation of 52 
intracellular RNA profiles, and make the meaningful comparison of intracellular datasets 53 
problematic. Figure 3 displays one such comparison of four publicly available microarray 54 
 11 
 
datasets describing the global response of M.tb to macrophage infection. Significant technical 1 
variation between studies makes the direct comparison of transcriptional profiles unwise; 2 
however the similarities between models are clearly visible. Interestingly, it is also possible to 3 
identify host-specific patterns that are represented across several datasets.  Further work will be 4 
required to ascertain the significance of such findings. 5 
 6 
 7 
FUTURE PERSPECTIVES 8 
 An understanding of the transcriptome of M.tb in the MΦ is developing and has identified a 9 
number of physiological changes the bacterium must undergo to survive within its specialised 10 
phagosome.  Most of this information comes from use of in vitro models of M.tb in MΦs or of 11 
axenic bacteria exposed to conditions considered to reflect the intracellular environment.  There 12 
have been some important studies investigating gene expression of M.tb in whole animal models 13 
184 36 185 186 187 39 and humans 188 38 189.   While in vitro studies are informative and an essential 14 
step in understanding the physiology of intracellular M.tb; the complexity of the environment in 15 
the host with the associated myriad of potential triggers of bacterial gene regulation mean that a 16 
full understanding of the intracellular transcriptomes of M.tb during its ongoing pathogenesis and 17 
continued survival in multiple microenvironments in the host will only be fully understood 18 
through in vivo investigations. Gene expression profiling of M.tb bacilli extracted from distinct 19 
stages of infection using human tissue and animal models will be required.  Although the mouse, 20 
guinea pig and rabbit are useful models of tuberculosis, the primate model of tuberculosis better 21 
reflects disease in humans 190 191.  Although challenging, studying the transcriptome of M.tb 22 
during the development of tuberculosis in the primate may give a greater understanding of the 23 
disease process in humans. 24 
 25 
 There are still areas of the host/pathogen interaction in tuberculosis that will greatly benefit 26 
from in vitro studies.  One area that has not been studied is the gene expression of M.tb exposed 27 
to apoptotic MΦs.  Apoptosis is a major killing mechanism of MΦs that has been shown to be 28 
very important in the control of M.tb 149 123 192.  M.tb has evolved mechanisms to inhibit apoptosis 29 
(which is protective for the host); instead M.tb induces necrosis in infected MΦ, which is 30 
beneficial to bacterial survival 153 157 156 193 123.  However, although gene expression by MΦs 31 
undergoing apoptosis or necrosis following infection with M.tb has been investigated 194, no 32 
study of the bacterial transcriptome in apoptotic versus necrotic MΦs has been undertaken.  As 33 
inhibition of apoptosis is a critical survival mechanism for M.tb, it will be of great interest to 34 
define the transcriptional basis of this process.   35 
 36 
 Another area that has not been extensively investigated at the level of bacterial gene 37 
expression is the comparison of virulent and avirulent M.tb in MΦs.  Some work has been done 38 
comparing M.tb with the attenuated vaccine strain, M.bovis BCG 55 but there are significant 39 
differences between M.tb and BCG which makes comparing the two strains difficult.  Recent 40 
work has compared the transcriptomes of a virulent strain of M.tb (H37Rv) with an avirulent 41 
strain (H37Ra) during growth in broth and identified a number of genes that are differentially 42 
regulated in the attenuated H37Ra that include members of the dormancy regulon and a number 43 
of genes connected to phoP expression 195 196 197.  Whether these differences are repeated when 44 
H37Rv and H37Ra are compared when inside MΦs awaits investigation, although one recent 45 
study has identified frdA-D among differentially regulated genes between intracellular H37Rv 46 
and H37Ra 30.  Transcriptional profiling of M.tb knockout mutants with specific in vivo 47 
phenotypes of compromised virulence 198 may become an important tool for defining the 48 
functional significance of single gene products and understanding the molecular determinants 49 
defining M.tb pathogenicity and virulence. 50 
 51 
 The intracellular transcriptomes of M.tb may help us to understand the physiological and 52 
metabolic states required by M.tb to successfully complete a cycle of human infection.   They 53 
may also be utilised as a bioprobe to discover and define microenvironments encountered by 54 
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bacilli during infection.   Additionally, they may facilitate the discovery of virulence mechanisms 1 
that enable M.tb bacilli to modulate the host immune response.  The identification of genes 2 
induced intracellularly suggests that they are important for the survival of M.tb in the host 3 
environment, and would therefore be possible candidate targets for therapeutic discovery 179.  As 4 
novel therapeutics are critically needed to control tuberculosis, especially with XDR M.tb 5 
becoming so prevalent 2, any strategy that facilitates drug discovery should be actively pursued.  6 
Additionally, these targets could act as potential candidates in rational vaccine design either to 7 
replace or augment the current BCG vaccine.  8 
 9 
 10 
EXECUTIVE SUMMARY 11 
Overview of the infectious process 12 
 M.tb binds to MΦ receptors and is ingested into a phagosome. 13 
 M.tb inhibits the development of the phagosome, holding it at the early endosome stage. 14 
 M.tb induces the production of cytokines that result in a TH1 adaptive immune response. 15 
 Through the activity of IFN and TNF, infected MΦ become activated and are better 16 
able to control the replication of M.tb through the action of Reactive Nitrogen 17 
Intermediates , Reactive Oxygen Intermediates and apoptosis. 18 
 M.tb then moves to a dormant state, often within a granuloma, and changes its physiology 19 
to combat the variation in oxygen tension, low carbohydrates and MΦ killing 20 
mechanisms. 21 
 22 
Binding and uptake (movement from extracellular to intracellular) 23 
 Non-opsonic uptake of M.tb is important in the serum free environment of the lung.  24 
 M.tb moderates its non-opsonic uptake by MΦ.  25 
 Transcriptional responses of M.tb begin within minutes of ingestion and include members 26 
of the devRS regulon and the phoPR regulon 27 
 A comparison of numerous microarray experiments identified common functionalities in 28 
M.tb regulated gene sets indicating a move to an environment low in carbohydrate, rich in 29 
lipid, low in oxygen and with toxic molecules present.  30 
 31 
Residence in a phagosome and the associated low nutrients, increased acidity and hypoxia. 32 
 M.tb maintains the phagosome at a mildly acidic pH and with markers indicating arrest at 33 
the early endosome stage with access to extracellular nutrients. 34 
 Nutrient deprivation, exposure to acidic pH and hypoxia have been used to model the 35 
phagosome. 36 
 This resulted in M.tb regulation of genes involved in oxidation of fatty acids, aerobic 37 
respiration, energy metabolism and lipid biosynthesis. 38 
 The devRS and phoPR regulons were upregulated. 39 
 40 
Exposure to potential mycobacteriacidal agents and processes  41 
 The major mycobacteriacidal mechanisms appear to be RNI, ROI and apoptosis. 42 
 ROI induces the upregulation of katG. 43 
 RNI induce the devRS regulon. 44 
 45 
The induction of adaptive immunity and the move to a dormancy profile. 46 
 Adaptive immunity is essential for the optimal control of M.tb. 47 
 The most important components of the effective adaptive response are IFN producing 48 
CD4+ve TH1 cells, CD8+ve cytolytic T cells and TNF. 49 
 IFN activates MΦ to better control the survival and replication of M.tb. 50 
 This induces dormancy in M.tb, characterised by lower rates of replication, use of lipids 51 
as a carbon source and a shift to microaerophilic respiration. 52 
 The dormancy regulon is dominated by the devRS regulon , genes involved in mycolic 53 
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Figure Legends 19 
 20 
Figure 1. Interaction of M.tb with macrophages. 21 
M. tuberculosis (M. tb) expressing a variety of Pathogen Associated Molecular Patterns 22 
(PAMPs), is recognized by Pattern Recognition Receptors (PRR) on host macrophages leading to 23 
BINDING and then UPTAKE.  During binding and uptake Reactive Oxygen Intermediates 24 
(ROI), Reactive Nitrogen Intermediates (RNI) and Cytokines are released by the macrophage.  25 
The INNATE immune response drives the ADAPTIVE response and, depending on the cytokine 26 
profile induced, will result in TH1 or TH2 and pro- or anti- inflammatory responses. The bacteria 27 
reside within an EARLY PHAGOSOME in which Rab5, coronin 1 and proCathepsin D (PCD) 28 
are found.  The mycobacterial phagosome also has a relatively high pH and has access to the  29 
extracellular milieu as shown by the cycling of transferrin.  Mycobacterial antigens are processed  30 
in some, as yet, poorly defined way leading to PRESENTATION.  Under some circumstances,  31 
mycobacteria are killed (xxx) and are then found in LATE PHAGOSOMES which contain Lamp 32 
1, Rab 7 and cathepsin D and also have a V-ATPase proton pump which acidifies the phagosome.  33 
The killing of intracellular mycobacteria can be mediated by RNI, ROI or through the 34 
INDUCTION OF APOPTOSIS which can be triggered by ROI, RNI and cytokines such as 35 
TNF.  36 
 37 
Figure 2. Dissecting the M.tb intracellular transcriptional profile.  38 
535 genes identified as significantly differentially expressed in two or more studies describing 39 
the M.tb response to macrophage infection (A-D). Genes identified (by the study authors) to be 40 
significantly induced (marked in red) or repressed (marked in blue) from in vitro axenic models 41 
broadly representing low pH (E-H), hypoxia (I-M), nutrient starvation (N-P) and oxidative stress 42 
(Q-S) are mapped alongside the intracellular response. Conditions are detailed as columns, genes 43 
as rows. The asterisked column represents an additive model describing the sum induction or 44 
repression of each gene from the axenic conditions. This rudimentary model shows the extent to 45 
which current in vitro modelling helps to define the M.tb intracellular profile. For example, Box 1 46 
highlights the hypoxic response as an integral element of the M.tb intracellular response. Box 2 47 
marks a cluster of genes differentially regulated by multiple in vitro environments. Box 3 shows 48 
the repression of ATP synthase and NAD dehydrogenase I (atp and nuo) gene families 49 
intracellularly. All M.tb axenic conditions relative to log phase untreated controls unless 50 
otherwise stated. (A) Murine bone marrow-derived MΦ (BMDM) 56. (B) Human monocyte-51 
derived MΦ (MDM), 60. (C) THP-1 human MΦ-like cells (THP-1), 92. (D) Murine BMDM 52 
relative to media control, 55. (E) Acid shock, 182. (F) Low pH, 93 (G) pH 6.5, 55 (H) pH 5.5 55. (I) 53 
Hypoxia, 97 (J) Non-replicating persistence-1 189 (K) Non-replicating persistence-2 189 (L) Non-54 
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replicating persistence or stationary phase 180 (M) Enduring hypoxic response 99 (N) Low glucose 1 
88 (O) Nutrient starvation 89 (P) Low copper 199 (Q) Reactive nitrogen intermediates 160 (R) 2 
Oxidative stress 200 (S) SDS stress 201 3 
 4 
Figure 3  The M.tb response to the intracellular environment.  5 
The transcriptional profile of 1121 genes (>2 fold differentially expressed in >2 conditions) were 6 
extracted, combined and clustered from four publicly available microarray datasets. 7 
Conditions/timepoints are displayed as columns, genes as rows. Red colouring indicates 8 
induction, blue repression compared to aerobic log phase growth (unless otherwise stated). 9 
MDM, human monocyte-derived MΦ infection model 60. BMDM, naïve and IFN-activated 10 
murine bone marrow-derived MΦs 56. THP, THP-1 human MΦ -like cell line infection model 92. 11 
BM, murine bone marrow-derived MΦ s infected with M.tb relative to bacilli resuspended in 12 
tissue culture media 55. Box A – genes differentially expressed after infection of human-derived 13 
cells only (MDM/THP). Box B – temporal response to infection observed in murine-derived cells 14 
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